Search

Search Results
Results 3521 - 3530 of 8241 for Skin Cancer
  • Drug - 19 Mar 2024
    Consumer Medicine Information (CMI) about Onivyde intended for persons living in Australia.
  • News - 12 Mar 2024
    A multidisciplinary research team at Gladstone Institutes, led by Senior Investigator Katie Pollard, PhD, has received $5 million in funding through a newly launched grant program designed to ignite a...
  • News - 11 Mar 2024
    A team of investigators from the UCLA Health Jonsson Comprehensive Cancer and the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute was awarded a $3.2 million...
  • Drug - 8 Mar 2024
    Consumer Medicine Information (CMI) about Depo-Ralovera intended for persons living in Australia.
  • Drug - 8 Mar 2024
    Consumer Medicine Information (CMI) about Depo-Provera intended for persons living in Australia.
  • Drug - 23 Feb 2024
    Consumer Medicine Information (CMI) about Mizart HCT (New) (Telmisartan and Hydrochlorothiazide) intended for persons living in Australia.
  • News - 21 Feb 2024
    A novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red blood cells, the hallmark of this malignancy and many of its...
  • Drug - 14 Feb 2024
    Consumer Medicine Information (CMI) about Mvasi intended for persons living in Australia.
  • Drug - 14 Feb 2024
    Consumer Medicine Information (CMI) about Bendamustine Viatris (Bendamustine hydrochloride powder for injection vial) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about DBL Methotrexate Injection intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.